Literature DB >> 30429370

Early expansion of donor-specific Tregs in tolerant kidney transplant recipients.

Thomas M Savage1, Brittany A Shonts1, Aleksandar Obradovic1, Susan Dewolf1, Saiping Lau1, Julien Zuber1, Michael T Simpson1, Erik Berglund1, Jianing Fu1, Suxiao Yang1, Siu-Hong Ho1, Qizhi Tang2, Laurence A Turka3,4, Yufeng Shen5, Megan Sykes1,6,7.   

Abstract

Allograft tolerance, in which a graft is accepted without long-term immunosuppression, could overcome numerous obstacles in transplantation. Human allograft tolerance has been intentionally induced across HLA barriers via combined kidney and bone marrow transplantation (CKBMT) with a regimen that induces only transient chimerism. Tregs are enriched early after CKBMT. While deletional tolerance contributes to long-term tolerance, the role of Tregs remains unclear. We have optimized a method for identifying the donor-specific Treg repertoire and used it to interrogate the fate of donor-specific Tregs after CKBMT. We expanded Tregs with several different protocols. Using functional analyses and T cell receptor sequencing, we found that expanding sorted Tregs with activated donor B cells identified the broadest Treg repertoire with the greatest potency and donor specificity of suppression. This method outperformed both alloantigen stimulation with CTLA4Ig and sequencing of CFSElo cells from the primary mixed lymphocyte reaction. In 3 tolerant and 1 nontolerant CKBMT recipients, we sequenced donor-specific Tregs before transplant and tracked them after transplant. Preexisting donor-specific Tregs were expanded at 6 months after CKBMT in tolerant patients and were reduced in the nontolerant patient. These results suggest that early expansion of donor-specific Tregs is involved in tolerance induction following CKBMT.

Entities:  

Keywords:  Immunology; Organ transplantation; T-cell receptor; Tolerance; Transplantation

Mesh:

Substances:

Year:  2018        PMID: 30429370      PMCID: PMC6302945          DOI: 10.1172/jci.insight.124086

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  42 in total

1.  Novel GMP-compatible protocol employing an allogeneic B cell bank for clonal expansion of allospecific natural regulatory T cells.

Authors:  S Landwehr-Kenzel; F Issa; S-H Luu; M Schmück; H Lei; A Zobel; A Thiel; N Babel; K Wood; H-D Volk; P Reinke
Journal:  Am J Transplant       Date:  2014-01-27       Impact factor: 8.086

2.  A converse 4-1BB and CD40 ligand expression pattern delineates activated regulatory T cells (Treg) and conventional T cells enabling direct isolation of alloantigen-reactive natural Foxp3+ Treg.

Authors:  Anne Schoenbrunn; Marco Frentsch; Siegfried Kohler; Jacqueline Keye; Hans Dooms; Beate Moewes; Jun Dong; Christoph Loddenkemper; Joachim Sieper; Peihua Wu; Chiara Romagnani; Nadine Matzmohr; Andreas Thiel
Journal:  J Immunol       Date:  2012-11-16       Impact factor: 5.422

3.  Regulatory T Cell Specificity Directs Tolerance versus Allergy against Aeroantigens in Humans.

Authors:  Petra Bacher; Frederik Heinrich; Ulrik Stervbo; Mikalai Nienen; Marco Vahldieck; Christina Iwert; Katrin Vogt; Jutta Kollet; Nina Babel; Birgit Sawitzki; Carsten Schwarz; Stefan Bereswill; Markus M Heimesaat; Guido Heine; Gabriele Gadermaier; Claudia Asam; Mario Assenmacher; Olaf Kniemeyer; Axel A Brakhage; Fátima Ferreira; Michael Wallner; Margitta Worm; Alexander Scheffold
Journal:  Cell       Date:  2016-10-20       Impact factor: 41.582

4.  The generation of donor-specific CD4+CD25++CD45RA+ naive regulatory T cells in operationally tolerant patients after pediatric living-donor liver transplantation.

Authors:  Hanaa Nafady-Hego; Ying Li; Hidenori Ohe; Xiangdong Zhao; Naoki Satoda; Shimon Sakaguchi; Kathryn Wood; Shinji Uemoto; Takaaki Koshiba
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

5.  Human T regulatory cells can use the perforin pathway to cause autologous target cell death.

Authors:  William J Grossman; James W Verbsky; Winfried Barchet; Marco Colonna; John P Atkinson; Timothy J Ley
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

Review 6.  Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism.

Authors:  Carrie Gibbons; Megan Sykes
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

7.  Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.

Authors:  A L Putnam; N Safinia; A Medvec; M Laszkowska; M Wray; M A Mintz; E Trotta; G L Szot; W Liu; A Lares; K Lee; A Laing; R I Lechler; J L Riley; J A Bluestone; G Lombardi; Q Tang
Journal:  Am J Transplant       Date:  2013-09-18       Impact factor: 8.086

8.  Expansion of human regulatory T-cells from patients with type 1 diabetes.

Authors:  Amy L Putnam; Todd M Brusko; Michael R Lee; Weihong Liu; Gregory L Szot; Taumoha Ghosh; Mark A Atkinson; Jeffrey A Bluestone
Journal:  Diabetes       Date:  2008-12-15       Impact factor: 9.461

9.  eulerAPE: drawing area-proportional 3-Venn diagrams using ellipses.

Authors:  Luana Micallef; Peter Rodgers
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

10.  TGFβ-dependent expression of PD-1 and PD-L1 controls CD8(+) T cell anergy in transplant tolerance.

Authors:  Marije Baas; Alix Besançon; Tania Goncalves; Fabrice Valette; Hideo Yagita; Birgit Sawitzki; Hans-Dieter Volk; Emmanuelle Waeckel-Enée; Benedita Rocha; Lucienne Chatenoud; Sylvaine You
Journal:  Elife       Date:  2016-01-29       Impact factor: 8.140

View more
  24 in total

1.  Twenty-year Follow-up of Histocompatibility Leukocyte Antigen-matched Kidney and Bone Marrow Cotransplantation for Multiple Myeloma With End-stage Renal Disease: Lessons Learned.

Authors:  Thomas R Spitzer; Nina Tolkoff-Rubin; A Benedict Cosimi; Steven McAfee; Bimalangshu R Dey; Yi-Bin Chen; Francis Delmonico; Megan Sykes; David H Sachs; Tatsuo Kawai
Journal:  Transplantation       Date:  2019-11       Impact factor: 4.939

2.  Resilience of T cell-intrinsic dysfunction in transplantation tolerance.

Authors:  Michelle L Miller; Christine M McIntosh; Ying Wang; Luqiu Chen; Peter Wang; Yuk Man Lei; Melvin D Daniels; Elyse Watkins; Carolina Mora Solano; Anita S Chong; Maria-Luisa Alegre
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-04       Impact factor: 11.205

Review 3.  Regulation of Alloantibody Responses.

Authors:  Anita S Chong; Peter T Sage; Maria-Luisa Alegre
Journal:  Front Cell Dev Biol       Date:  2021-07-08

4.  Siplizumab selectively depletes effector memory T cells and promotes a relative expansion of alloreactive regulatory T cells in vitro.

Authors:  Manuel A Podestà; Christian Binder; Felix Sellberg; Susan DeWolf; Brittany Shonts; Siu-Hong Ho; Aleksandar Obradovic; Elizabeth Waffarn; Nichole Danzl; David Berglund; Megan Sykes
Journal:  Am J Transplant       Date:  2019-08-13       Impact factor: 9.369

Review 5.  Emerging Concepts of Tissue-resident Memory T Cells in Transplantation.

Authors:  Jianing Fu; Megan Sykes
Journal:  Transplantation       Date:  2022-11-24       Impact factor: 5.385

6.  Foxp3+ Regulatory and Conventional CD4+ T Cells Display Similarly High Frequencies of Alloantigen-Reactive Cells.

Authors:  Mélanie Lalfer; Pascal Chappert; Maxime Carpentier; Dominique Urbain; Jean M Davoust; David-Alexandre Gross
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

7.  Safety and pharmacodynamics of anti-CD2 monoclonal antibody treatment in cynomolgus macaques - an experimental study.

Authors:  Erik Berglund; Paula Alonso-Guallart; Makenzie Danton; Felix Sellberg; Christian Binder; Robin Fröbom; David Berglund; Nathaly Llore; Hiroshi Sakai; Alina Iuga; Dilrukshi Ekanayake-Alper; Keith A Reimann; David H Sachs; Megan Sykes; Adam Griesemer
Journal:  Transpl Int       Date:  2019-11-15       Impact factor: 3.842

8.  Deletion of donor-reactive T cell clones after human liver transplant.

Authors:  Thomas M Savage; Brittany A Shonts; Saiping Lau; Aleksandar Obradovic; Harlan Robins; Abraham Shaked; Yufeng Shen; Megan Sykes
Journal:  Am J Transplant       Date:  2019-10-03       Impact factor: 9.369

Review 9.  The Immunological Basis of Liver Allograft Rejection.

Authors:  Vincenzo Ronca; Grace Wootton; Chiara Milani; Owen Cain
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

Review 10.  Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review.

Authors:  Priscila Ferreira Slepicka; Mahboubeh Yazdanifar; Alice Bertaina
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.